Norway· NO-ID_A2383DDE-5F7C-4631-A83A-163A76142382
Fasenra
A benralizumab product containing benralizumab, registered in Norway by AstraZeneca AB (2). The same ATC class is registered in 16 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Benralizumab is registered in 16 of 19 countries.
Countries holding a registration under ATC R03DX10 (benralizumab), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 10 of them publish a price we can compare per daily dose
Benralizumab · ATC R03DX10
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Benralizumab
- Manufacturer
- AstraZeneca AB (2)
- Country
- Norway (NO)
- ATC code
- R03DX10
- ATC class
- Benralizumab
- Defined daily dose
- 0.54 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_A2383DDE-5F7C-4631-A83A-163A76142382
- no_varenummer44969730NOK 34065.9
- gtin5000456079112
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Benralizumab in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenFasenra 30 mg Injektionsvätska, lösning i förfylld injektionspennaAstraZeneca AB
- BelgiumFasenra 30 mgAstraZeneca
- CzechiaFASENRAAstraZeneca AB, Södertälje
- SpainFASENRA 30 MG SOLUCION INYECTABLE EN JERINGA PRECARGADAAstrazeneca Ab
- United KingdomFasenra 30mg/1ml solution for injection pre-filled pensAstraZeneca UK Ltd
- IcelandFasenraAstraZeneca AB
- SwitzerlandFasenra
- FinlandFasenraAstraZeneca AB
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Fasenra
- Liechtenstein · Fasenra
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2443c8d4-1248-4a91-a3b3-cb84877738ea GET /v1/drugs/2443c8d4-1248-4a91-a3b3-cb84877738ea?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Injeksjonsvæske, oppløsning i ferdigfylt penn",
"source": "fest",
"status": "A",
"atc_name": "Benralizumab",
"merkevare_id": "ID_A2383DDE-5F7C-4631-A83A-163A76142382",
"name_form_strength": "Fasenra inj, oppl 30 mg/penn",
"prescription_group": "C"
}See everything about benralizumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.